How a Publicly Traded Gene Therapy Company Optimized Construct Design with FORMsightAI
While cell and gene therapies have the potential to save lives and revolutionize medicine, the trial-and-error manufacturing process can consume valuable time and capital, creating significant risks for companies.
In this case study you'll learn about:
- The common challenges in rAAV modeling and production
- The economic drivers pointing to the need for manufacturing optimized design
- How FORMsightAI predictively reduced the truncations that impact development cost and time-to-market
Complete the form and you'll receive a PDF of the case study.